View Older Stories View More Recent Stories
-
Companies with NDRs 1/15
-
Matinas BioPharma Announces Closing of Public Offering of Common Stock
-
Matinas BioPharma Announces Closing of Public Offering of Common Stock
-
Tengasco (TGC) to Review Potential Business Combination Alternatives
-
Tengasco Announces Review Of Potential Business Combination Alternatives
-
Tilly's (TLYS) PT Lowered to $12 at Roth Capital
-
Endeavour Silver Corp (EXK) PT Lowered to $2.70 at Roth Capital
-
New Age Beverages (NBEV) Names David Vanderveen as COO
-
New Age Beverages (NBEV) Announces Joins Newage as COO
-
David Vanderveen Joins Newage as Chief Operating Officer
-
David Vanderveen Joins Newage as Chief Operating Officer
-
Oncolytics Biotech® Provides Recap of Key Opinion Leader Call Highlighting Pelareorep's Unique Ability to Activate the Immune System in Late Stage Multiple Myeloma
-
ROTH Capital Partners Bolsters its Healthcare Franchise with Key Hires
-
Roth Capital Starts Millendo Therapeutics Inc. (MLND) at Buy
-
Matinas BioPharma (MTNB) Prices 32.26M Shares at $1.55
-
Matinas BioPharma Announces Pricing of Public Offering of Common Stock
-
Matinas BioPharma Announces Pricing of Public Offering of Common Stock
-
Oncolytics Biotech® Announces Key Opinion Leader Call Conducted by ROTH Capital Partners to Discuss Multiple Myeloma
-
Mirum Pharmaceuticals, Inc. (MIRM) Prices 2.4M Share Common Offering at $20/Sh
-
Mirum Pharmaceuticals Announces Pricing of Public Offering
-
Himax Technologies (HIMX) PT Raised to $4 at Roth Capital
-
UPDATE: Roth Capital Starts Kodiak Sciences Inc. (KOD) at Buy
-
Verona Pharma Appoints David Moskowitz as Vice President, Capital Markets Strategy & Investor Relations
-
Verona Pharma Appoints David Moskowitz as Vice President, Capital Markets Strategy & Investor Relations
-
First Solar (FSLR) Class Action Settlement 'Positive' - Roth Capital
-
Plug Power (PLUG) Award Raises Growth Visibility, Expect More - Roth Capital
-
Roth Capital Downgrades Coeur d'Alene Mines (CDE) to Sell
-
Darling International (DAR) PT Raised to $38 at Roth Capital, Top Pick for 2020
-
Musk defies skeptics, meets Tesla delivery goal; shares hit record
-
Renewable Energy Group (REGI) PT Raised to $33 at Roth Capital
-
Roth Capital Reiterates Buy Rating on Sequans Communications (SQNS), Says Co To Be Top Semi/IoT Performer in 2020
-
Arcimoto Inc. (FUV) PT Lowered to $5 at Roth Capital
-
UPDATE: Roth Capital Transfers Coverage on Zynerba Pharmaceuticals (ZYNE) at Buy
-
Roth Capital Downgrades AquaVenture Holdings (WAAS) to Neutral Following Acquisition
-
Roth Capital Downgrades AquaVenture Holdings (WAAS) to Neutral
-
Roth Capital Starts Crinetics (CRNX) at Buy
-
Roth Capital Starts Oxurion NV (OXUR:BB) (TBGNF) at Buy
-
NV5 Completes the Acquisition of Quantum Spatial, Schedules January 7 Conference Call to Discuss Strategic Benefits
-
Roth Capital Starts Cresco Labs Inc. (CL:CN) (CRLBF) at Buy
-
Pre-Open 12/19: (PRTK) (RAD) (TIVO) Higher (NERV) (APOG) (XPER) Lower (more...)
-
After-Hours Movers 12/18: (AMPE) (NBEV) (MU) Higher; (NERV) (MLHR) (GDOT) Lower (more...)
-
Roth Capital Starts Inovio Pharmaceuticals (INO) at Buy
-
UPDATE: Roth Capital Starts X4 Pharmaceuticals (XFOR) at Buy
-
Roth Capital Starts Yeti Holdings Inc. (YETI) at Buy
-
Akoustis Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Akoustis Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Forty Seven, Inc. Announces Closing of Underwritten Public Offering and Exercise in Full of Option to Purchase Additional Shares
-
Forty Seven, Inc. Announces Closing of Underwritten Public Offering and Exercise in Full of Option to Purchase Additional Shares
-
Exclusive: ProSieben's NuCom looks at Meet Group acquisition - sources
-
Azure Power Global Limited (AZRE) PT Raised to $24 at Roth Capital

